Search

everythinglearnresearchcommunity

for

Search:↓

Hydroxychloroquine may cause false results in tuberculosis tests for patients with autoimmune skin diseases.

Certain medications can cause serious side effects, so it's important to report them.

The model showed that immune system guardians and the cytokine interferon-γ are key in alopecia areata progression.

A hepatitis B patient lost hair in patches after starting and stopping a treatment with pegylated interferon alpha2a.

Vitamin D helps protect skin, PSORS1 gene's risk interval for psoriasis is expanded, hair follicles can be generated from mouse cells, and interferon-γ may cause pigmented skin lesions.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Rodent models helped understand psoriasis but none perfectly replicated the disease.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

COVID-19 infection may trigger alopecia areata in some patients.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Mesenchymal stem cells in people with Hidradenitis Suppurativa are more inflammatory, possibly contributing to the disease.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

JAK inhibitors show promise for treating hair loss in alopecia areata but need more clinical trials to confirm safety and effectiveness.

Different treatments for alopecia areata have unpredictable results and varying success rates.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Mesenchymal stem cell therapy may help treat alopecia areata by promoting hair growth and reducing inflammation.